基于知识产权全链条的生物医药企业创新能力评价研究OA
Research on the Evaluation of the Innovation Capability of Biopharmaceutical Enterprises Based on the Full Chain of Intellectual Property
本文基于特色中药民族药产业、化学药产业、生物技术药物产业、医疗器械产业、海洋生物医药产业等五个生物医药产业,5个二级分类及12个细分技术领域,从知识产权创造、运用、保护、管理全链条模型建立企业创新能力评价指标体系,综合评价生物医药企业知识产权创新能力.结果表明,生物医药产业整体知识产权创新能力水平优良,其中化学药产业创新能力水平综合评分优势明显;生物医药企业在各个细分领域知识产权的创造能力总体表现较好,但在知识产权运用能力水平方面整体偏低.
This paper examines five biopharmaceutical industries including ethnic drugs of unique tradi-tional Chinese medicine,chemical medicine,biotechnology drugs,medical devices,and marine bio-medicine as well as five secondary categories and 12 subdivided technical fields.Based on the full chain model of the creation,application,protection,and management of intellectual property,it builds an index system for evaluating the innovation capability of enterprises as a way to make a comprehen-sive assessment of the innovation capability of the intellectual property of biopharmaceutical enterpri-ses.The results indicate that the biopharmaceutical industry has good innovation capability of intellec-tual property as a whole,and the chemical pharmaceutical industry stands out in the comprehensive e-valuation of the innovation capability with a significant advantage;and biopharmaceutical enterprises have a strong creative ability of intellectual property in all subdivided fields,but with poor performance in the application of intellectual property.
谭芳香;王海伶;侯圣君;周惠
广西壮族自治区知识产权发展研究中心(广西南宁530022)广西壮族自治区知识产权发展研究中心(广西南宁530022)广西壮族自治区知识产权发展研究中心(广西南宁530022)广西壮族自治区知识产权发展研究中心(广西南宁530022)
生物工程
生物医药知识产权全链条创新能力评价体系
BiomedicineIntellectual PropertyFull ChainInnovation CapabilityEvaluation System
《科技广场》 2024 (3)
62-72,11
广西科技发展战略研究专项"RCEP国家科技创新发展指数分析及广西与RCEP国家重点产业专利技术转移合作研究"(项目编号:桂科ZL23014002)广西知识产权项目"广西生物医药产业专利导航应用示范"(项目编号:桂知ZX2022026)
评论